Oruka Therapeutics, Inc. · NASDAQ:ORKA

Agarwal Arjun sold 533 Oruka Therapeutics, Inc. shares (Form 4)

Traded Sep 21, 2026 · Filed Sep 21, 2026

On Sep 21, 2026, Agarwal Arjun (Senior Vice President, Finance) sold 533 Oruka Therapeutics, Inc. shares at US$95.75 for US$51,035 under a trading plan, leaving 14,219 shares. Filed Sep 21, 2026 (Form 4).

Sold
533 shares
Price
US$95.75
Value
US$51,035
Holding after
14,219 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Senior Vice President, Finance

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 21, 2026Common StockSale533US$95.7514,219Direct

Source

View original at SEC

Related